These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 20493864)

  • 1. Persistent reflux symptoms in the proton pump inhibitor era: the changing face of gastroesophageal reflux disease.
    Dellon ES; Shaheen NJ
    Gastroenterology; 2010 Jul; 139(1):7-13.e3. PubMed ID: 20493864
    [No Abstract]   [Full Text] [Related]  

  • 2. Reflux inhibitors: a new approach for GERD?
    Boeckxstaens GE
    Curr Opin Pharmacol; 2008 Dec; 8(6):685-9. PubMed ID: 18771751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapies for gastroesophageal reflux disease.
    Bredenoord AJ
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):129-38. PubMed ID: 20485251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor failure--what are the therapeutic options?
    Fass R
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease.
    Tack J
    Curr Opin Gastroenterol; 2005 Jul; 21(4):454-60. PubMed ID: 15930988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Sweis R; Anggiansah A; Wong T
    Clin Gastroenterol Hepatol; 2010 Mar; 8(3):313. PubMed ID: 19788931
    [No Abstract]   [Full Text] [Related]  

  • 7. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
    Friedlander EA; Pallentino J; Miller SK; VanBeuge SS
    J Am Acad Nurse Pract; 2010 Dec; 22(12):674-83. PubMed ID: 21129076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastroesophageal reflux disease--diagnosis and management].
    Wojtuń S; Gil J; Jałocha Ł; Błaszak A; Wojtkowiak M
    Pol Merkur Lekarski; 2009 May; 26(155):512-6. PubMed ID: 19606713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal sphincter device for gastroesophageal reflux disease.
    Ganz RA; Peters JH; Horgan S; Bemelman WA; Dunst CM; Edmundowicz SA; Lipham JC; Luketich JD; Melvin WS; Oelschlager BK; Schlack-Haerer SC; Smith CD; Smith CC; Dunn D; Taiganides PA
    N Engl J Med; 2013 Feb; 368(8):719-27. PubMed ID: 23425164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of gastroesophageal reflux disease in elderly people].
    Masharova AA; Bordin DS
    Eksp Klin Gastroenterol; 2007; (4):37-40. PubMed ID: 18411443
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel therapeutics for gastro-esophageal reflux symptoms.
    Zerbib F; Simon M
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):533-41. PubMed ID: 23121276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weakly acidic reflux.
    Tack J; Blondeau K
    Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
    Mine S; Iida T; Tabata T; Okada Y; Tanaka Y
    J Gastroenterol Hepatol; 2008 Feb; 23(2):303-9. PubMed ID: 17725600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency scale symptoms for gastroesophageal reflux disease (Frequency Scale for Symptoms of GERD) predicts need for addition of prokinetics to proton pump inhibitor therapy.
    Nandurkar S
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1165-7. PubMed ID: 18699977
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic options for refractory gastroesophageal reflux disease.
    Fass R
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():3-7. PubMed ID: 22486864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in gastroesophageal reflux disease diagnosis and therapy.
    Ali T; Miner PB
    Curr Opin Gastroenterol; 2008 Jul; 24(4):502-8. PubMed ID: 18622167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non response to proton pump inhibitors in gastroesophageal reflux disease].
    Lochner S; Kirch W
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1956. PubMed ID: 19760560
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.
    Haag S; Andrews JM; Katelaris PH; Gapasin J; Galmiche JP; Hunt R; Layer P; Malfertheiner P; Holtmann G
    Digestion; 2009; 80(4):226-34. PubMed ID: 19844107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroesophageal reflux disease: endoscopy, duration of treatment, and choice of PPI.
    Greenspan NR
    Med Health R I; 2011 Apr; 94(4):92-4. PubMed ID: 21667598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.